NCT05292859View on ClinicalTrials.gov

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Gynecologic CancerColorectal CancerPancreatic CancerNon-small Cell Lung CancerCholangiocarcinomaOvarian CancerOvary NeoplasmSquamous Cell Lung CancerAdenocarcinoma of LungAdenosquamous Cell Lung Cancer
Interventions
BIOLOGICAL

Neoantigen specific TCR-T cell drug product

No study drug is administered in this study. Patients who have received Neoantigen specific TCR-T cell drug product will be evaluated in this trial for long-term safety and efficacy

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY

NCT05292859 - Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | Biotech Hunter | Biotech Hunter